leisure time -WSS

leisure time

author：hotspot 2025-10-02 00:40:29 - browse：6562

Humana’s Medicare Advantage enrollees got care in the hospital and physician clinics way more often than the company predicted at the end of 2023, forcing the health insurance giant on Thursday to drastically slash its profit projections for both 2023 and 2024.

Those higher medical costs will wipe away more than $775 million of profit that Humana had expected to bank for 2023. Humana also is “currently assessing the expected impact of emerging utilization trends on its 2024 outlook, which is anticipated to be material if current trends continue,” according to the company’s update to investors.

Humana’s bad news for Wall Street didn’t end there: The company said it appears it only added just 100,000 new Medicare Advantage members from the most recent enrollment period that ended last month — down from estimates that it would enroll anywhere from 325,000 to 435,000 people.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Neuroscience’s long legacy of racism

WSS

Asbestos, a deadly carcinogen, banned by EPA

Virtual Event: March of the Biosimilars

Study: Adult vaccinations pay for themselves in societal benefits

Physicians and social media: If you see something, say something?

Readout Newsletter: Bluebird, CVS, Contineum

Creating egg and sperm cells from stem cells raises ethical issues

hotspot

leisure time

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

CDC wastewater surveillance dashboard to track bird flu hotspots

In age of alternative facts, a scholarly course on calling out crap

H5N1 communication has been strictly for the birds

Supreme Court strikes down use of affirmative action

Medicare says breakthrough device reimbursement rule to come by summer

Virginia high school admissions case could be legal follow

Readout LOUD podcast: brain research, obesity drug sales, Novartis

United colonoscopy coverage change 'may cost lives,' doctors say

U.K. researchers warn about biases in medical devices, algorithms

knowledge

SCOTUS questions limit to govt efforts to fight misinformation

Orchard's therapy for neuron disease in children wins FDA approval

Making AI in medicine accessible to smaller, and rural hospitals

Making AI in medicine accessible to smaller, and rural hospitals

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

Positive childhood experiences can help future health

hotspot

hotspot

entertainment

focus